Effector CD8(+) T cell engraftment and anti-tumor immunity in lymphodepleted hosts is IL-7Rα dependent

Por Johnson, C. Bryce, Riesenberg, Brian P., May, Bennett R., Gilreath, Stuart C., Li, Guangfu, Staveley-O’Carroll, Kevin F., Garrett-Mayer, Elizabeth, Mehrotra, Shikhar, Cole, David J., Rubinstein, Mark P.
Publicado no Cancer Immunol Res (2015)

Enhanced lymphodepletion is insufficient to replace exogenous IL-2 or IL-15 therapy in augmenting the efficacy of adoptively transferred effector CD8(+) T cells

Por Johnson, C. Bryce, May, Bennett R., Riesenberg, Brian P., Suriano, Samantha, Mehrotra, Shikhar, Garrett-Mayer, Elizabeth, Salem, Mohamed L., Jeng, Emily K., Wong, Hing C., Paulos, Chrystal M., Wrangle, John, Cole, David J., Rubinstein, Mark P.
Publicado no Cancer Res (2018)